23 May 2018, London, UK
The Microbiome Invest Congress 2018 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
“The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (2019–2023)” Human Microbiome Market Industry Report – Markets and Markets
Pitch Your Microbes
Central to MICROBIOME INVEST is ‘Pitch Your Microbes’, a platform for 12 of the most exciting emerging companies in microbiome to pitch their innovative ideas to a room full of potential advisors, investors, and partners. Our esteemed selection committee will handpick these final 12 presenting companies from the list of all applicants.
To apply, you should meet one of the following entry criteria:
– An academic with a desire to develop and commercialise an innovative idea or piece of research that will benefit patients.
– A recent spin-out from an academic institution looking for financial investment, partnerships, and advice.
– A biotech company at the pre-revenue or post-revenue stage, looking for financial investment, partnerships, licensing deals and advice.